Brief: Prometheus Biosciences Says Board Has Appointed Mark Mckenna To Succeed Tadataka Yamada As Chairman
Aug 23 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* PROMETHEUS BIOSCIENCES - BOARD HAS APPOINTED MARK C.
MCKENNA TO
SUCCEED TADATAKA YAMADA AS CHAIRMAN
* PROMETHEUS BIOSCIENCES - BOARD HAS DETERMINED TO APPOINT
JOSEPH
C. PAPA TO SERVE AS LEAD INDEPENDENT DIRECTOR
* PROMETHEUS BIOSCIENCES - BOARD REDUCED ITS SIZE FROM 9 TO
8
DIRECTORS
Source text for Eikon: [https://bit.ly/3gohtjS]
Further company coverage: RXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results